Professor of Radiation Oncology, UCLA
Radiation Oncology
Dr. Patrick A. Kupelian, MD
|
|
Give Review
Doctor Patrick A. Kupelian, MD works in the field of Radiation Oncology. He over the years received 7 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Best Doctors", "Top Doctors:Southern California" and "Exemplary Physician Colleague Award". Doctor Patrick A. Kupelian, MD is also published. He has 101 publications published. The lastest publication: "SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk p...'
Publications
- The significance of PTV dose coverage on Cancer control outcomes in early stage non-small cell lung Cancer patients treated with highly ablative stereotactic body radi...
- In Regard to Bauman et al.
- SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk p...
- Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate Cancer.
- Dosimetric benefits of hemiGland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.
- Dosimetric feasibility of magnetic resonance imaging-guided tri-cobalt 60 preoperative intensity modulated radiation therapy for soft tissue sarcomas of the extremity.
- Dosimetric parameters predict short-term quality-of-life outcomes for patients receiving stereotactic body radiation therapy for prostate Cancer.
- Incorporating Cancer Stem Cells in Radiation Therapy Treatment Response Modeling and the Implication in Glioblastoma Multiforme Treatment Resistance.
- Dependence of Achievable Plan Quality on Treatment Technique and Planning Goal Refinement: A Head-and-Neck Intensity Modulated Radiation Therapy Application.
- Does the Addition of Targeted Prostate Biopsies to Standard Systemic Biopsies Impact Treatment Management for Radiation Oncologists?
- A GPU based high-resolution multilevel biomechanical head and neck model for validating deformable image registration.
- Late rectal toxicity after low-dose-rate brachytherapy: Incidence, predictors, and management of side effects.
- 4Ï Noncoplanar Stereotactic Body Radiation Therapy for Head-and-Neck Cancer: Potential to Improve Tumor Control and Late Toxicity.
- Stereotactic body radiation therapy for prostate Cancer: Rational and reasonable.
- Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
- A nonvoxel-based dose convolution/superposition algorithm optimized for scalable GPU architectures.
- Multiparametric MRI identifies and stratifies prostate Cancer lesions: Implications for targeting intraprostatic targets.
- Accelerating Dynamic Magnetic Resonance Imaging (MRI) for Lung Tumor Tracking Based on Low-Rank Decomposition in the Spatial-Temporal Domain: A Feasibility Study Based...
- 4D-CT Lung registration using anatomy-based multi-level multi-resolution optical flow analysis and thin-plate splines.
- Health-Related Quality of Life After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Results From a Multi-institutional Consortium of Prospective Tr...
- Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate Cancer.
- Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
- Real-Time Tumor Tracking in the Lung Using an Electromagnetic Tracking System.
- Assessment of Interfraction Patient Setup for Head-and-Neck Cancer Intensity Modulated Radiation Therapy Using Multiple Computed Tomography-Based Image Guidance.
- 4? Noncoplanar Stereotactic Body Radiation Therapy for Centrally Located or Larger Lung Tumors.
- A client-server framework for 3D remote visualization of radiotherapy treatment space.
- Multi-scale, multi-modal image integration for image-guided clinical interventions in the head and neck anatomy.
- Focal high-dose-rate brachytherapy: A dosimetric comparison of hemiGland vs. conventional whole-Gland treatment.
- Evaluation of High Ipsilateral Subventricular Zone Radiation Therapy Dose in Glioblastoma: A Pooled Analysis.
- Modeling Airflow Using Subject-Specific 4DCT-Based Deformable Volumetric Lung Models.
- The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, an...
- 4-Coplanar Liver SBRT: A Novel Delivery Technique.
- A multi-GPU real-time dose simulation software framework for lung radiotherapy.
- An Endorectal Balloon Reduces Intrafraction Prostate Motion During Radiotherapy.
- Redefining High-risk Prostate Cancer Based on Distant Metastases and Mortality After High-dose Radiotherapy with Androgen Deprivation Therapy.
- Expanding the use of real-time electromagnetic tracking in radiation oncology.
- A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate Cancer.
- A comparison of soft-tissue implanted markers and bony anatomy alignments for image-guided treatments of head-and-neck Cancers.
- Comparison of transabdominal ultrasound and electromagnetic transponders for prostate localization.
- Dosimetric effect of prostate motion during helical tomotherapy.
- Dosimetric effects of rotational output variation and x-ray target degradation on helical tomotherapy plans.
- Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate Cancer.
- Megavoltage computed tomography image-based low-dose rate intracavitary brachytherapy planning for cervical carcinoma.
- Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging.
- Outcomes for intermediate risk prostate Cancer: are there advantages for surgery, external radiation, or brachytherapy?
- A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate Cancer.
- Assessment of parotid Gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration.
- Observations on real-time prostate Gland motion using electromagnetic tracking.
- Effect of increasing radiation doses on local and distant failures in patients with localized prostate Cancer.
- Patient dose from megavoltage computed tomography imaging.
- Evaluation of image-guidance strategies in the treatment of localized prostate Cancer.
- Investigation of accelerated partial breast patient alignment and treatment with helical tomotherapy unit.
- Impact of image guidance on outcomes after external beam radiotherapy for localized prostate Cancer.
- Image-guided radiotherapy for localized prostate Cancer: treating a moving target.
- Implantation and stability of metallic fiducials within pulmonary lesions.
- Pathologic stage migration has slowed in the late PSA era.
- Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced...
- Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate Cancer treated with adjuvant or salvage radiotherapy.
- Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate Cancer: Cleveland Clinic experience.
- Positional stability of electromagnetic transponders used for prostate localization and continuous, real-time tracking.
- Evaluation of image-guidance protocols in the treatment of head and neck Cancers.
- A model for predicting lung Cancer response to therapy.
- Optical tracking technology in stereotactic radiation therapy.
- Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.
- Characterization and use of EBT radiochromic film for IMRT dose verification.
- Daily variations in delivered doses in patients treated with radiotherapy for localized prostate Cancer.
- Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate Cancer patients treated with external beam radiation therapy a...
- Evaluation of an infrared camera and X-ray system using implanted fiducials in patients with lung tumors for gated radiation therapy.
- Daily variations in the position of the prostate bed in patients with prostate Cancer receiving postoperative external beam radiation therapy.
- Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate Cancer.
- Aggressiveness of familial prostate Cancer.
- Increasing external beam dose for T1-T2 prostate Cancer: effect on risk groups.
- Influence of intrafraction motion on margins for prostate radiotherapy.
- Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate Cancer.
- Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy.
- Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy.
- PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate Cancer: a multi-institutional analysis.
- A technique for adaptive image-guided helical tomotherapy for lung Cancer.
- Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate Cancer: long-term outcomes.
- Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung Cancer: observations on tumor regression during treatment.
- Performance characterization of megavoltage computed tomography imaging on a helical tomotherapy unit.
- Initial experience with megavoltage (MV) CT guidance for daily prostate alignments.
- Intraprostatic fiducials for localization of the prostate Gland: monitoring intermarker distances during radiation therapy to test for marker stability.
- Seeking help for erectile dysfunction after treatment for prostate Cancer.
- Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model.
- Continuing trends in pathological stage migration in radical prostatectomy specimens.
- Salvage radiotherapy for recurrent prostate Cancer after radical prostatectomy.
- Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should w...
- Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiothe...
- Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate Cancer.
- Long-term multi-institutional analysis of stage T1-T2 prostate Cancer treated with radiotherapy in the PSA era.
- Improvement in relapse-free survival throughout the PSA era in patients with localized prostate Cancer treated with definitive radiotherapy: year of treatment an indep...
- Localized prostate Cancer: radiation or surgery?
- Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
- The use of treatments for erectile dysfunction among survivors of prostate carcinoma.
- Defining sexual outcomes after treatment for localized prostate carcinoma.
- Comparison of the efficacy of local therapies for localized prostate Cancer in the prostate-specific antigen era: a large single-institution experience with radical pr...
- Brain metastases from gynecological Cancers: factors that affect overall survival.
- Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate wi...
- Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prosta...
Schools
American University Of Beirut Faculty Of Medicine
American University Beirut
MD Anderson Cancer Center University Texas
Cleveland Clin Found
Conditions Treated
- Pituitary Gland Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Best Doctors
- Top Doctors:Southern California
- Exemplary Physician Colleague Award
Education
-
University of Texas MD Anderson Cancer Center -
American University of Beirut Faculty of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144205881 |
| Last Name Of The Provider | KUPELIAN |
| First Name Of The Provider | PATRICK |
| View All |
Similar Doctors
|
|
Dr. Mark Fireman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Tomas Dvorak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Buchholz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey G. Brabham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Burkhard Weppelmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Sollaccio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akash Nanda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafael R. Manon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristin W. Houseknecht, MD |
|
|
Dr. Donald W. Jenkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John S. Ravita, MD
This Doctor is OpenDoctor Recommended.
|